Skip to content

News

PDRN vs polynucleotides UK: what works best?

PDRN vs polynucleotides UK, why the confusion?

If you have seen viral “salmon sperm” serums online, you are not alone in wondering whether a topical PDRN product can match injectable polynucleotides for hydration, fine lines, texture or under-eye crepiness.

The short, evidence-led answer is that topical PDRN skincare and injectable polynucleotides are not equivalent. They can both have a place in a good skin plan, but they work at different depths, with different expectations.

What do the terms mean?

  • Polynucleotides (PN) are chains of nucleotides (DNA fragments) commonly derived from salmon or trout sources and purified for medical use.
  • PDRN (polydeoxyribonucleotide) is a specific type and size range of DNA fragments. In everyday marketing, PDRN is often used as an umbrella term.

In clinic conversations, you may hear “PN”, “PDRN”, “polynucleotide skin boosters” or “regenerative injectables”. The key practical difference for patients is usually topical skincare versus injectable medical product, rather than the exact naming.

How topical PDRN skincare works, and its realistic limits

Topical PDRN products are usually serums or creams positioned as soothing, “repairing” or “regenerating”. They may be useful, but expectations should be grounded in how skin absorbs ingredients.

What topical PDRN can realistically do

Topical PDRN is most realistic for surface-level support, especially when paired with a well-formulated base.

  • Barrier support: Improving how the skin feels and functions when it is dry, sensitised or irritated.
  • Comfort and soothing: Some people find reduced tightness and improved feel, particularly after professional treatments.
  • Hydration and glow: Often due to supporting ingredients in the formula (humectants, soothing agents, occlusives), rather than DNA fragments alone.
  • Post-procedure aftercare: It may be used as part of a gentle routine after treatments where your clinician has advised topical use.

What topical PDRN is unlikely to do

Even excellent skincare has limits because the outer layer of the skin is designed to keep large molecules out.

  • True dermal remodelling: Significant collagen or elastin change in the dermis is unlikely from topical PDRN alone.
  • Meaningful tightening or lifting: Skincare can improve appearance, but it will not replicate energy-based tightening or injectables.
  • Deep under-eye crepiness improvement: Under-eye skin is thin and sensitive, and topical changes tend to be subtle.
  • Acne scar structural change: Scars in the dermis usually need procedures that reach the correct depth.

Who might choose topical PDRN?

Topical PDRN may suit you if:

  • You want low-risk, low-commitment skin support.
  • You are needle-averse.
  • You are maintaining results after in-clinic procedures.
  • You have reactive skin and are focusing on barrier repair (alongside a clinician-approved routine).

Injectable polynucleotides, what they are best for

Injectable polynucleotides are delivered into the skin with fine needles or cannula. Because they are placed within the skin rather than on top, they are used for concerns where a topical product typically cannot reach.

In practice, injectable PN is often chosen to support skin quality, rather than to add volume. Patients usually describe aims such as better hydration, improved texture, a healthier look, and softening of fine lines.

Common treatment areas and concerns

Injectable polynucleotides are often considered for:

  • Under-eye crepiness and fine lines (when suitable, and not primarily a volume problem)
  • Neck lines and neck skin quality
  • Hands (crepey texture, dry appearance)
  • Cheeks and lower face skin quality (fine lines, dehydration, dullness)
  • Acne scar quality as part of a broader plan (often combined with devices or resurfacing)

Polynucleotides are not a replacement for treatments designed to lift, reduce strong muscle activity, or restore significant volume.

Typical course, downtime and when you see results

Protocols vary by product, anatomy and goals. A common approach is a course rather than a one-off.

  • Typical plan: 2–4 sessions, spaced around 2–4 weeks apart.
  • Early changes: Hydration and glow can be noticed in the first few weeks.
  • Skin quality changes: Texture and fine lines typically evolve over 6–12 weeks and may continue improving after the course.
  • Maintenance: Many people consider top-ups every 3–6 months, depending on response and skin concerns.

Downtime is usually limited, but not zero:

  • Small bumps (injection blebs) for 24–72 hours, depending on technique and product
  • Mild swelling, especially under the eyes
  • Bruising risk, particularly around thin skin and in patients who bruise easily

What results are realistic?

A realistic outcome is healthier-looking skin, not a new face.

You might expect:

  • Improved hydration and softness
  • Smoother texture and less “crepey” look in suitable areas
  • Subtle softening of fine lines
  • Better skin resilience over time

You should not expect:

  • A surgical lift effect
  • Dramatic reduction of deep folds
  • Major volume restoration (fillers are different)
  • Instant scar erasure

Safety and UK-specific considerations

Because injectable polynucleotides are medical treatments, safety depends on product choice, storage, technique, anatomy knowledge and infection control.

Who should be cautious or avoid treatment

Your clinician may advise delaying or avoiding treatment if you:

  • Are pregnant or breastfeeding
  • Have an active skin infection, cold sore outbreak, or significant inflammatory flare in the area
  • Have a history of severe allergic reactions, or have reacted to injectable products before
  • Have uncontrolled autoimmune disease or are on certain immunosuppressive medications (this needs individual assessment)
  • Have bleeding disorders or are taking blood-thinning medication, where bruising risk is higher (do not stop prescribed medication without medical advice)

Side effects to understand

Topical PDRN:

  • Irritation, stinging or rash is possible with any skincare, often due to fragrance, preservatives or other actives
  • Breakouts can occur if the base is too occlusive for your skin type

Injectable polynucleotides:

  • Temporary swelling, redness and tenderness
  • Bruising
  • Small lumps or unevenness that usually settle
  • Infection risk (rare but important), requiring prompt medical review
  • Vascular complications are uncommon with superficial skin treatments, but any injectable carries risk, which is why clinician training and safety protocols matter

Choosing a safe UK provider

In the UK, choose a clinic that:

  • Uses traceable, legitimate products with appropriate clinical oversight
  • Offers a face-to-face assessment and explains alternatives
  • Provides clear aftercare and a pathway for urgent concerns
  • Does not oversell “regeneration” or promise guaranteed results

Decision framework, what to choose for your main concern

The best choice depends on what is driving the issue, dehydration, pigment, redness, laxity, scarring, or volume loss.

Quick comparison table

Concern Topical PDRN skincare Injectable polynucleotides Adjuncts that may help
Dehydration and dullness Helpful, especially for barrier support Often helpful, deeper hydration and skin quality LED, medical-grade skincare plan
Fine lines (early) Modest improvement, mainly from hydration Often helpful over weeks Fractional RF (Morpheus8), Sylfirm X, retinoids if suitable
Under-eye crepiness Limited, and irritation risk Common indication when suitable Careful under-eye plan, sometimes energy devices, sometimes tear trough filler if volume loss
Pores and rough texture Can help surface feel Can help overall quality, but not a pore “erase” Sylfirm X, Morpheus8, chemical peels, CO2 in selected cases
Redness and sensitivity Often helpful as barrier-focused support Sometimes used, but redness often needs diagnosis Vascular lasers (where appropriate), rosacea management
Acne scars Limited Can support skin quality as part of a plan CO2 laser, microneedling RF, subcision, targeted scar protocols
Early laxity Minimal Subtle improvement in skin quality, not a lift Morpheus8, other tightening modalities, tailored plan
Neck lines Limited Often considered RF microneedling, skincare and sun protection
Hands (crepey) Helpful for dryness Often helpful for crepey texture Skin boosters, resurfacing options

Practical guide, who should choose which?

Choose topical PDRN skincare if:

  • Your main issue is dryness, irritation or barrier disruption
  • You want a gentle add-on to support recovery after procedures
  • You prefer gradual, subtle improvements and minimal risk

Consider injectable polynucleotides if:

  • You are seeking deeper skin quality change in areas like under-eyes, neck or hands
  • You have tried good skincare but still feel texture and crepiness persist
  • You understand that results are gradual and best achieved with a course

Consider combination plans if:

  • You have mixed concerns, for example texture plus laxity, or scars plus pigmentation
  • You want the best chance of improvement, while still keeping it natural

Where Morpheus8, Sylfirm X, CO2 and LED fit

Polynucleotides are often used alongside devices because they target different parts of the problem.

  • Morpheus8 (RF microneedling): Targets texture, pores, and tightening by stimulating collagen at controlled depths. Downtime can include redness, swelling and grid marks.
  • Sylfirm X (RF microneedling with pulsed wave): Often chosen for texture plus redness, and for some pigment concerns, depending on skin type and assessment.
  • CO2 laser: Strong resurfacing option for lines and scars in selected patients, with more downtime and a higher risk profile, especially in deeper skin tones.
  • LED: Supportive option for redness and recovery, typically minimal downtime and often used as an adjunct.

A clinician may recommend spacing treatments to reduce irritation and optimise healing.

Key takeaways

  • PDRN vs polynucleotides UK is often a comparison of topical skincare versus injectable treatment.
  • Topical PDRN can support comfort and barrier function, but it is unlikely to create deep structural change.
  • Injectable polynucleotides can improve skin quality gradually, particularly for under-eye crepiness, neck and hands, but results are subtle and require a course.
  • Safety comes from proper assessment, legitimate products, sterile technique and realistic planning.

If you are unsure which approach fits your skin and priorities, you can be assessed by experienced medical professionals at Renovatio Clinic.

Tags: